Sort by
Refine Your Search
-
ROLE SUMMARY As a member of our Oncology Research Unit (ORU) In Vivo Pharmacology and Project Leadership group, you will lead a group focused on developing and implementing in vivo strategies
-
clinicians or contingent workers assigned to the project; may supervise, mentor, and/or develop others. QUALIFICATIONS Science degree (PhD, PharmD) and minimum of 9 years Clinical Research experience in
-
translation of pre-clinical observations into clinical experiments and studies designed to demonstrate proof of pharmacology, proof of mechanism and proof of concept for new candidate medicines. The CL will
-
Oncology first-in-human clinical trials with input from Oncology Research Unit, Oncology Regulatory Strategy, Clinical Pharmacology and Precision Medicine, Oncology Clinical Development and Operations, Pharm
-
advanced science and technologies into the therapies and vaccines that matter most. Whether you are in the discovery sciences, ensuring drug safety and efficacy or supporting clinical trials, you will apply
-
clinical development and commercial priorities for Pfizer Oncology. QUALIFICATIONS: Education MD, MD/PhD or equivalent with extensive clinical experience. Experience 10+ years of oncology development
-
approaches. You will partner with key stakeholders and colleagues in Clinical Pharmacology, Quantitative Systems Pharmacology, Statistics, Translational Modeling and Simulation, and other Research and
-
. QUALIFICATIONS Basic Qualifications PhD in Molecular or Cellular Biology, Biochemistry, Genetics/Genomics, Pharmacology, or related field with typically 3+ years of relevant postdoctoral experience in an academic
-
Oncology first-in-human clinical trials with input from Oncology Research Unit, Oncology Regulatory Strategy, Clinical Pharmacology and Precision Medicine, Oncology Clinical Development and Operations, Pharm
-
ROLE SUMMARY Pfizer's Oncology Research Unit (ORU) in La Jolla, California, is seeking a Senior Scientist (PhD) focused on translating basic discoveries in the field of cancer epigenetics into novel